• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION THE Q-TRAK SUBCUTANEOUS ELECTRODE; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION THE Q-TRAK SUBCUTANEOUS ELECTRODE; IMPLANTABLE LEAD Back to Search Results
Model Number 3010
Device Problems Failure to Convert Rhythm (1540); Defibrillation/Stimulation Problem (1573); Under-Sensing (1661)
Patient Problems Ventricular Fibrillation (2130); Electric Shock (2554)
Event Date 05/02/2023
Event Type  Injury  
Event Description
It was reported that this subcutaneous implantable cardioverter defibrillator (s-icd) delivered a shock which converted the ventricular tachycardia (vt) over to ventricular fibrillation (vf).Two more shocks were delivered and converted the vf back to sinus rhythm with the third shock.Data was provided for review, boston scientific technical services confirmed the accelerated rhythm and noted that the third shock successfully terminated the rhythm.There could be multiple root causes of these occurring including inappropriate vector selection, sensing issues, and inappropriate programming.Device optimization programming suggestions were provided.No additional adverse patient effects were reported.This device and electrode remain in-service.
 
Event Description
It was reported that this subcutaneous implantable cardioverter defibrillator (s-icd) delivered a shock which converted the ventricular tachycardia (vt) over to ventricular fibrillation (vf).Two more shocks were delivered and converted the vf back to sinus rhythm with the third shock.Data was provided for review, boston scientific technical services confirmed the accelerated rhythm and noted that the third shock successfully terminated the rhythm.There could be multiple root causes of these occurring including inappropriate vector selection, sensing issues, and inappropriate programming.Device optimization programming suggestions were provided.No additional adverse patient effects were reported.This device and electrode remain in-service.
 
Manufacturer Narrative
This product has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.
 
Manufacturer Narrative
This product has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.Please refer to b5 describe event or problem for more information regarding the specific circumstances of this event.
 
Event Description
It was reported that this subcutaneous implantable cardioverter defibrillator (s-icd) delivered a shock which converted the ventricular tachycardia (vt) over to ventricular fibrillation (vf), which got initially under-sensed.Two more shocks were delivered and converted the vf back to sinus rhythm with the third shock.Data was provided for review, boston scientific technical services confirmed the accelerated rhythm and noted that the third shock successfully terminated the rhythm.There could be multiple root causes of these occurring including inappropriate vector selection, sensing issues, and inappropriate programming.Device optimization programming suggestions were provided.No additional adverse patient effects were reported.This device and electrode remain in-service.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THE Q-TRAK SUBCUTANEOUS ELECTRODE
Type of Device
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key16996174
MDR Text Key315877198
Report Number2124215-2023-26053
Device Sequence Number1
Product Code LWS
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P110042/S000
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 09/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/24/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date03/01/2016
Device Model Number3010
Device Catalogue Number3010
Device Lot NumberA112799
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/25/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Other;
-
-